相关实验视频
Updated: Jan 6, 2026
10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
5.2K
在跨阶段期间,在专利管道动脉支架之后重新进行干预
James R Bentham1, Sok-Leng Kang2
1Yorkshire Heart Centre, Leeds General Infirmary, Great George Street, Leeds, UK. jamie.bentham@nhs.net.
Pediatric cardiology
|October 4, 2025
概括
静脉管的支架是患有先天性心脏病的婴儿的替代方案. 有时需要对支架管道进行重新干预以促进生长,这带来了独特的挑战.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 干预心脏病学 干预心脏病学
- 遗传性心脏病是一种先天性心脏病.
背景情况:
- 静脉管 (ductus arteriosus) 的支架是患有导管依赖性先天性心脏病的婴儿的常见缓解策略.
- 虽然支架是有效的,但在随后的手术缓和之前,支架往往需要重新干预.
- 由于复杂的解剖学和程序,这段间期存在挑战.
研究的目的:
- 审查与婴儿在支架管道上的再干预相关的挑战.
- 讨论提高程序效率和安全的技术考虑因素.
- 探索计划重新干预的可能性,以优化增长.
主要方法:
- 复习临床经验与支架管道再干预.
- 对解剖学和程序复杂性的讨论.
- 对减轻新生儿和婴儿并发症的策略进行分析.
主要成果:
- 为了获得最佳的结果,经常需要对支架管道进行重新干预.
- 解剖学复杂性和程序性挑战增加了重新干预的需要.
- 计划的重新干预可以促进体质和血管的生长.
结论:
- 对支架管道的重新干预是管理管道依赖先天性心脏病的关键方面.
- 仔细的技术考量是必不可少的,以最大限度地降低婴儿的风险.
- 通过计划的再干预来优化增长是一个可行的策略.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
202
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
202
01:26Aneurysm III: Interprofessional Care
233
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
233